National

GOOD NEWS : GLENMARK LAUNCHES ORAL ANTIVIRAL DRUG FABIFLUEFOR TREATMENT OF COVID 19

June 20, 2020 05:24 PM

 Mumbai (Face2News)

The Glenmark pharmaceutical  launches oral antiviral drug fabiflue for mild to moderate Covid 19 in India. The approval in this regard have been granted. The company got formal approval of Indian Drug Regulator on Friday to manufacture and marketing in India. 

The approval was granted on the basis of evaluation of Data and consultation with the subject expert committee. as part of accelerated approval process, considering the emergency situation and unmet medical need of Covid 19 outbreak.

Have something to say? Post your comment
Copyright © 2017, Face 2 News, All rights reserved. Terms & Conditions Privacy Policy Disclaimers